Maintenance treatment of Crohn's disease with a polymeric feed rich in TGF-β

Annals of Gastroenterology

Volumn 23, Issue 2, 2010, Pages 113-118

  Triantafillidis, J K ^a   Stamataki, A ^a   Karagianni, V ^a   Gikas, A ^a   Malgarinos, G ^a  

^a Saint Panteleimon General State Hospital   (Greece)

Author keywords

Crohn's disease; Immunomodulation; Inflammatory bowel disease; Milk; Transforming growth factor

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; MESALAZINE; TRANSFORMING GROWTH FACTOR BETA2;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DIET THERAPY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; REMISSION; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL;

EID: 77952941867     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. MacDonald TT, Di Sabatino A, Gordon JN. Immunopathogenesis of Crohn's disease. JPEN J Parenter Enteral Nutr 2005;29(4 Suppl):S118-124.
2. Gassull MA, Cabre E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2001;4:561-569.
3. Murphy MS. Growth factors and the gastrointestinal tract. Nutrition 1998;14:771-774.
4. Oz HS, Ray M, Chen TS, McClain CJ. Efficacy of a transforming growth factor beta 2 containing nutritional support formula in a murine model of inflammatory bowel disease. J Am Coll Nutr 2004;23:220-226.
5. Schiffrin EJ, Yousfi ME, Faure M, Combaret L, Donnet A, Blum S, Obled C, Breuille D. Milk casein-based diet containing TGF-beta controls the inflammatory reaction in the HLA-B27 transgenic rat model. JPEN J Parenter Enteral Nutr 2005;29(4 Suppl):S141-148
6. Fell JME, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in pediatric Crohn's disease. Aliment Pharmacol The 2000;14:281-289.
7. Beattle RM, Schiffrin EJ, Donnet-Hughes A, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol The 1994;8:609-615
8. Hartman C, Berkowitz D, Weiss B, Shaoul R, Levine A, Adiv OE, Shapira R, Fradkin A, Wilschanski M, Tamir A, Shamir R. Nutritional supplementation with polymeric diet enriched with transforming growth factor-beta 2 for children with Crohn's disease. Isr Med Assoc J 2008;10:503-507.
9. Triantafillidis JK, A. Stamataki, A. Gikas, M. Sklavaina, M. Mylonaki, F. Georgopoulos, et al. Beneficial effect of a polymeric feed, rich inTGF-β, on adult patients with active Crohn's disease: a pilot study. Annals Gastroenterol 2006;19:66-71.
10. Benchimol EI, Seow CH, Otley AR, Steinhart AH. Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009;(1):CD002913.
11. Cammΰ C, Giunta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn's disease: a meta-ana-lysis adjusted for confounding variables. Gastroenterology 1997;113:1465-1473.
12. Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009;(1):CD000067.
13. Behm BW, Bickston SJ. Tumor necrosis factor-alpha anti-body for maintenance of remission in Crohn's disease. Co-chrane Database Syst Rev 2008;(1):CD006893.
14. Donnet-Hughes A, Duc N, Serrant P, Vidal K, Schiffrin EJ. Bioactive molecules in milk and their role in health and disease: The role of transforming growth factor-β. Immunol Cell Biol 2000;78:74-79.
15. Campos FG, Waitzberg DL, Teixeria MG, Mucerino DR, Habr-Gama A, Kiss DR. Inflammatory bowel disease: principles of nutritional therapy. Rev Hosp Clin Fac 2002;57:187-192.
16. MacDonald TT, Di Sabatino A, Gordon JN. Immunopathogenesis of Crohn's disease. J Parenter Enteral Nutr 2005;29(4 Suppl):S118-124.
17. Bannerjee K, Camacho-Hubner C, Babinska K, et al. Antiinflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn's disease. J Pediatric Gastroenterol Nutr 2004;38:270-275.
18. Lionetti P, Callegari ML, Ferrari S, Cavicchi MC, Pozzi E, de Martino M, Morelli L. Enteral nutrition and microflora in pediatric Crohn's disease. J Parenter Enteral Nutr 2005;29(4 Suppl):S173-175
19. Dupont B, Dupont C, Justum AM, Piquet MA, Reimund JM. Enteral nutrition in adult Crohn's disease: present status and perspectives. Mol Nutr Food Res 2008;52:875-884.
20. Fell JM. Control of systemic and local inflammation with transforming growth factor beta containing formulas. JPEN J Parenter Enteral Nutr 2005;29(4 Suppl):S126-128.
21. Harsha WT, Kalandarova E, McNutt P, Irwin R, Noel J. Nutritional supplementation with transforming growth factor-beta, glutamine, and short chain fatty acids minimizes methotrexate-induced injury. J Pediatr Gastroenterol Nutr 2006;42:53-58.
22. Woodman AC, Claerk P, Watanapa P, et al. Effect of luminal growth factor preservation on intestinal growth. Lancet 1993;341:843-847.
23. Tabet F, Rye KA. High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) 2009;116:87-98.